If you or someone you know received the drug Trasylol® before, during or after open heart or bypass surgery followed by a stroke, heart attack or kidney problems, acting fast and seeking legal advice immediately is one of the most important things you can do. The personal injuries and wrongful deaths caused by Trasylol® have only begun to emerge and it appears to be yet another example of a pharmaceutical company profiting from a dangerous drug that injures patients.
The statute of limitations varies from state to state. Patients injured by Trasylol® should hire lawyers who are experts in dealing with drug companies to provide the legal care you deserve and to protect their rights.

Click here to contact attorneys dedicated to providing personal legal care who have an outstanding record of representing individuals harmed by defective products. Read what our clients say about the support we provided when they needed help most.

Trasylol®, which is made from the lung tissue of cattle, was meant to limit bleeding during heart-related surgeries and eliminate the need for transfusions. It was first approved by the FDA in 1993. It had grown into a lucrative product for Bayer, achieving $338 million in sales in 2005.

But two recent studies concluded that death rates due to complications skyrocketed when the drug was used. Not only were patients suffering heart attacks and strokes, but also encephalopathy and brain damage.

In February 2007 in the Journal of the American Medical Association, a study showed that the drug accounted for a 50 percent increase in the risk of death. In the study, the patients were treated between November 1996 and December 2006. The researchers assessed survival of patients after six weeks, six months, and annually for five years following surgery by 1,072 patients who received Trayslol, 834 who received aminocaproic acid, and 442 who received Cyklokapron. After five years, there were 223 deaths in the Trayslol group, 132 in the aminocaproic acid group and 65 in the Cyklokapron group.

Trasylol® doubled the risk of kidney failure and heart failure. The risk of stroke, as identified in the study, conducted by the Ischemia Research and Education Foundation, was determined to be 181 percent higher for Trasylol® patients.

Evidence was overwhelming that this drug was shortening lives and causing grave agony to the families of victims. But in September 2007, an FDA advisory panel recommended that Trasylol® should remain on the market despite the mounting evidence of its dangers. Patients continued to receive it.

In November 2007, Bayer AG pulled Trasylol® from the market following a request by the FDA to remove the drug.

Now countries all over the world have taken steps to ban the drug. Even China recently suspended the drug.

For patients, it’s imperative to act now, find out if you have a valid claim for damages and understand all of your legal options. The legal system will not act for you until you take charge. That’s why you need experienced lawyers to work with you to take all appropriate legal action.

Click here to introduce yourself and to find out if we can help you. No recovery: no charges.

Free personal injury consultation.   Guaranteed confidential.

Call 1.888.777.1776.

Monday through Friday 7 am  to 9 pm Pacific; Saturday and Sunday 10 am to 9 pm Pacific.

Or email us.

For all personal injury and wrongful death clients: no recovery: no fees, no costs.

Delay can result in the permanent loss of personal injury rights.  Don’t put it off.  Call now.


Richard Alexander